cancer
Conditions
Interventions
Sponsors
Hu'nan Cancer Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: (1) aged 18-60 years; (2) BMI in the normal range (1+/-20%); (3) diagnosis of lung cancer, breast cancer, cervical cancer, colorectal cancer, with surgical indications, no distant metastasis; (4) ASA grade I-II; (5) no thymosin A1, Chinese Medicine (Bazhen Tang) use contraindications; (6) before the test, the patients or their legal representatives understand and voluntarily sign the ethics Informed consent approved by the Committee.
Exclusion criteria
Exclusion criteria: (1) had participated in other clinical trials within 4 weeks before the start of this study; (2) used albumin and immunoenhancer drugs within 15 days before operation; (3) had a history of coronavirus infection, direct or indirect exposure, had fever, cough; (4) had previous immune deficiency; (5) had congenital metabolic abnormalities and other diseases; (6) Patients with autoimmune diseases and infections; (7) pregnant and lactating women; (8) who were not willing to participate in the study for any reason.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| postoperative complication;occupancy rate of intensive care unit;2-year tumor-free survival and overall survival; | — |
Secondary
| Measure | Time frame |
|---|---|
| prognostic nutritional index;immune-inflammationindex;CD4+T cell;CD8+T cell;the ratio of CD4/CD8;Treg cell;CD44+T cell;TNF-alpha;IL-17; | — |
Countries
China
Contacts
Public ContactYang Jinfeng
Hu'nan Cancer Hospital
Outcome results
None listed